This study highlights crucial molecular mechanisms in PCa progression, particularly the significance of BAIAP2L2 as a potential therapeutic target, warranting further investigation into additional hub genes for effective targeted strategies. This evidence concerns the gene BAIAP2L2 and posterior cortical atrophy.